EGFR and neoplasm: However, its fast degradation in vivo in combination with low tumor activity uptake levels along with pronounced activity concentration in the liver, kidney and intestine, obtained in tumor-bearing rat biodistribution studies, rendered [11C]-ML03 ineffective as a tracer for imaging of the EGFR [99].